Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2016 1
2018 2
2019 1
2020 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Real-world clinical effectiveness and safety of CT-P10 in patients with diffuse large B-cell lymphoma: An observational study in Europe.
Bishton MJ, Salles G, Golfier C, Knauf W, Bocchia M, Turner D, Slama B, Harchowal J, Marshall S, Bosi A, Lleonart JJB, Welslau M, Kim S, Lee YN, Zinzani PL, Laribi K. Bishton MJ, et al. Among authors: harchowal j. EJHaem. 2022 Nov 6;4(1):45-54. doi: 10.1002/jha2.593. eCollection 2023 Feb. EJHaem. 2022. PMID: 36819165 Free PMC article.
The safety and clinical effectiveness of rapid infusion with CT-P10 in patients with non-Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non-interventional post-authorization safety study in Europe.
Bishton M, Marshall S, Harchowal J, Salles G, Golfier C, Tucci A, Fernández AR, Sanchez Blanco JJ, Bocchia M, Kim S, Lee YN, Zinzani PL. Bishton M, et al. Among authors: harchowal j. Hematol Oncol. 2022 Aug;40(3):370-380. doi: 10.1002/hon.2978. Epub 2022 Mar 17. Hematol Oncol. 2022. PMID: 35168291 Free PMC article.
International Society of Oncology Pharmacy Practitioners global position on the use of biosimilars in cancer treatment and supportive care.
Frazer MB, Bubalo J, Patel H, Siderov J, Cubilla M, De Lemos M, Dhillon H, Harchowal J, Kuchonthara N, Livinalli A, Macedo R, Mwangi W, Nomura H, O'Connor S, Patterson M, Seadi Torriani M, Yim B, Chan A, Foreman E. Frazer MB, et al. Among authors: harchowal j. J Oncol Pharm Pract. 2020 Apr;26(3_suppl):3-10. doi: 10.1177/1078155219893441. J Oncol Pharm Pract. 2020. PMID: 32268831
Intravenous iron sucrose: establishing a safe dose.
Chandler G, Harchowal J, Macdougall IC. Chandler G, et al. Among authors: harchowal j. Am J Kidney Dis. 2001 Nov;38(5):988-91. doi: 10.1053/ajkd.2001.28587. Am J Kidney Dis. 2001. PMID: 11684551 Clinical Trial.
Can doctors identify older patients at risk of medication harm following hospital discharge? A multicentre prospective study in the UK.
Parekh N, Stevenson JM, Schiff R, Graham Davies J, Bremner S, Van der Cammen T, Harchowal J, Rajkumar C, Ali K; PRIME study group. Parekh N, et al. Among authors: harchowal j. Br J Clin Pharmacol. 2018 Oct;84(10):2344-2351. doi: 10.1111/bcp.13690. Epub 2018 Jul 30. Br J Clin Pharmacol. 2018. PMID: 29957885 Free PMC article.
Protocol for a Prospective (P) study to develop a model to stratify the risk (RI) of medication (M) related harm in hospitalized elderly (E) patients in the UK (The PRIME study).
Stevenson J, Parekh N, Ali K, Timeyin J, Bremner S, Van Der Cammen T, Allen J, Schiff R, Harchowal J, Davies G, Rajkumar C. Stevenson J, et al. Among authors: harchowal j. BMC Geriatr. 2016 Jan 19;16:22. doi: 10.1186/s12877-016-0191-8. BMC Geriatr. 2016. PMID: 26787530 Free PMC article.